Medication Guide App

R 626 (Zafirlukast 20 mg)

Pill imprint R 626 has been identified as Zafirlukast 20 mg.

Zafirlukast is used in the treatment of asthma, maintenance and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Zafirlukast 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for R 626

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)